NEA Management Company’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

NEA Management Company’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-66,245	Closed	-$1.6M	–	48
2017 Q2	$1.6M	Hold	66,245	–	–	0.06%	41
2017 Q1	$1.27M	Hold	66,245	–	–	0.04%	36
2016 Q4	$1.02M	Hold	66,245	–	–	0.04%	35
2016 Q3	$862K	Hold	66,245	–	–	0.04%	38
2016 Q2	$921K	Sell	66,245 -58,759	-47%	-$865K	0.05%	39
2016 Q1	$1.9M	Hold	125,004	–	–	0.13%	35
2015 Q4	$2.37M	Hold	125,004	–	–	0.15%	30
2015 Q3	$2.38M	Sell	125,004 -48,888	-28%	-$1.22M	0.16%	33
2015 Q2	$4.48M	Hold	173,892	–	–	0.23%	32
2015 Q1	$5.44M	Sell	173,892 -2	-0%	-$57	0.25%	33
2014 Q4	$6.7M	Sell	173,894 -2	-0%	-$48	0.33%	31
2014 Q3	$4.24M	Hold	173,896	–	–	0.22%	31
2014 Q2	$4.15M	Hold	173,896	–	–	0.19%	28
2014 Q1	$6.43M	Hold	173,896	–	–	0.32%	26
2013 Q4	$7.01M	Hold	173,896	–	–	0.34%	26
2013 Q3	$6.64M	Hold	173,896	–	–	0.26%	28
2013 Q2	$6.3M	Buy	+173,896	New	+$7.45M	0.28%	28

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

NEA Management Company's PRTK Position: Q3 2017 in Review

NEA Management Company sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2017, closing a stake of 66,245 shares — an estimated $1.6M sold.

NEA Management Company first reported a position in PRTK in Q2 2013 and held it in 17 quarters. The position peaked at $7.01M in Q4 2013. 133 funds tracked by Wall St. Rank hold PRTK as of Q3 2017.

NEA Management Company reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
NEA Management Company sold 66,245 Paratek Pharmaceuticals, Inc. shares in Q3 2017, an estimated $1.6M.
NEA Management Company first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
NEA Management Company's Paratek Pharmaceuticals, Inc. position peaked at $7.01M in Q4 2013.
133 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2017.

Based on NEA Management Company's 13F filing for Q3 2017, filed 3 Nov 2017.